64 related articles for article (PubMed ID: 3279619)
1. A new method of immunosuppression by selective destruction of cytotoxic T cells with photodynamic effect.
Sakurada M; Satomi S; Taguchi Y; Mori S
Transplant Proc; 1988 Feb; 20(1 Suppl 1):305-8. PubMed ID: 3279619
[No Abstract] [Full Text] [Related]
2. New method of immunosuppression by selective destruction of CTL by a photodynamic effect.
Satomi S; Sakurada M; Morimoto K; Satake M; Ohtsuki S; Takeda Y; Amada N; Taguchi Y; Mori S
Transplant Proc; 1989 Feb; 21(1 Pt 1):1134-6. PubMed ID: 2650078
[No Abstract] [Full Text] [Related]
3. Immunomodulation: UV radiation.
Transplant Proc; 1988 Feb; 20(1 Suppl 1):302-8. PubMed ID: 2964749
[No Abstract] [Full Text] [Related]
4. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts.
Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP
Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803
[No Abstract] [Full Text] [Related]
5. Modulation of arachidonic acid metabolism and cytotoxic T lymphocyte function.
Jendrisak M; Mangino M; Peters S; Anderson C
Transplant Proc; 1989 Feb; 21(1 Pt 1):174-7. PubMed ID: 2784891
[No Abstract] [Full Text] [Related]
6. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
Madsen JC; Peugh WN; Wood KJ; Morris PJ
Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
[No Abstract] [Full Text] [Related]
7. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
Yamada J; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
[TBL] [Abstract][Full Text] [Related]
8. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
Lake P; Sabbadini E; Sehon AH
Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
10. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
[No Abstract] [Full Text] [Related]
11. Induction of T cell proliferation and cytotoxicity by lymphokines.
Männel DN; Falk W; Dröge W
Lymphokine Res; 1985; 4(2):133-8. PubMed ID: 3923276
[No Abstract] [Full Text] [Related]
12. [Inactivation of allogeneic stem cells by lymphocytes identical as regards the H2 system of tissue compatibility].
Petrov RV; Egorov IK; Seslavina LS; Panteleev EI; Egorova OS
Dokl Akad Nauk SSSR; 1974; 219(6):1489-91. PubMed ID: 4155671
[No Abstract] [Full Text] [Related]
13. In vitro generation of allogeneic rather than syngeneic cytotoxic T cells for leukemia therapy.
Steinmann J; Glass B; Herwartz C; Salomo M; Sebens T; Uharek L; Müller-Ruchholtz W
Transplant Proc; 1995 Feb; 27(1):637-9. PubMed ID: 7879128
[No Abstract] [Full Text] [Related]
14. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Bobbio SA; Wood ML; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
[No Abstract] [Full Text] [Related]
15. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens].
Nesterenko VG; Gruner ShG
Biull Eksp Biol Med; 1980 Jun; 89(6):708-10. PubMed ID: 6967339
[TBL] [Abstract][Full Text] [Related]
16. Genetic studies and effect on skin allograft survival of DBA-2 DAG, Ly, and M-locus antigens.
Sachs JA; Huber B; Peña-Martinez J; Festenstein H
Transplant Proc; 1973 Dec; 5(4):1385-7. PubMed ID: 4590621
[No Abstract] [Full Text] [Related]
17. The optimal activation of cytotoxic T lymphocytes requires metabolically intact stimulator cells not only for the activation of the interleukin 2-producing helper cells.
Dröge W; Männel D; Falk W; Schmidt H; Panknin S; Dotterer W
J Immunol; 1983 Jul; 131(1):520-8. PubMed ID: 6223082
[No Abstract] [Full Text] [Related]
18. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
Jorgensen PN; Florentz K; Güttler F
Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
[No Abstract] [Full Text] [Related]
20. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
Lee R; Glimcher LH; Auchincloss H
Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
